Click for best price
Cancer Genome Sequencing Market Size, Share 2022
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
This report contains market size and forecasts of Cancer Genome Sequencing in Global, including the following market information:
Global Cancer Genome Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Genome Sequencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Second Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Genome Sequencing include Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, Abbott Laboratories, Beckman Coulter, Bayer, Hamilton Thorne Biosciences and Integrated DNA Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Genome Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genome Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Type, 2021 (%)
Second Generation
Third Generation
Global Cancer Genome Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Application, 2021 (%)
Treatment
Research
Global Cancer Genome Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Genome Sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genome Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Genome Sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
| Report Attributes |
Report Details |
| Report Title |
Cancer Genome Sequencing Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Genome Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genome Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genome Sequencing Overall Market Size
2.1 Global Cancer Genome Sequencing Market Size: 2021 VS 2028
2.2 Global Cancer Genome Sequencing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genome Sequencing Players in Global Market
3.2 Top Global Cancer Genome Sequencing Companies Ranked by Revenue
3.3 Global Cancer Genome Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Sequencing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Genome Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genome Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Genome Sequencing Market Size Markets, 2021 & 2028
4.1.2 Second Generation
4.1.3 Third Generation
4.2 By Type - Global Cancer Genome Sequencing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genome Sequencing Revenue, 2017-2022
4.2.2 By Type - Global Cancer Genome Sequencing Revenue, 2023-2028
4.2.3 By Type - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genome Sequencing Market Size, 2021 & 2028
5.1.2 Treatment
5.1.3 Research
5.2 By Application - Global Cancer Genome Sequencing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genome Sequencing Revenue, 2017-2022
5.2.2 By Application - Global Cancer Genome Sequencing Revenue, 2023-2028
5.2.3 By Application - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Genome Sequencing Market Size, 2021 & 2028
6.2 By Region - Global Cancer Genome Sequencing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genome Sequencing Revenue, 2017-2022
6.2.2 By Region - Global Cancer Genome Sequencing Revenue, 2023-2028
6.2.3 By Region - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Genome Sequencing Revenue, 2017-2028
6.3.2 US Cancer Genome Sequencing Market Size, 2017-2028
6.3.3 Canada Cancer Genome Sequencing Market Size, 2017-2028
6.3.4 Mexico Cancer Genome Sequencing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Genome Sequencing Revenue, 2017-2028
6.4.2 Germany Cancer Genome Sequencing Market Size, 2017-2028
6.4.3 France Cancer Genome Sequencing Market Size, 2017-2028
6.4.4 U.K. Cancer Genome Sequencing Market Size, 2017-2028
6.4.5 Italy Cancer Genome Sequencing Market Size, 2017-2028
6.4.6 Russia Cancer Genome Sequencing Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Genome Sequencing Market Size, 2017-2028
6.4.8 Benelux Cancer Genome Sequencing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Genome Sequencing Revenue, 2017-2028
6.5.2 China Cancer Genome Sequencing Market Size, 2017-2028
6.5.3 Japan Cancer Genome Sequencing Market Size, 2017-2028
6.5.4 South Korea Cancer Genome Sequencing Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Genome Sequencing Market Size, 2017-2028
6.5.6 India Cancer Genome Sequencing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Genome Sequencing Revenue, 2017-2028
6.6.2 Brazil Cancer Genome Sequencing Market Size, 2017-2028
6.6.3 Argentina Cancer Genome Sequencing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genome Sequencing Revenue, 2017-2028
6.7.2 Turkey Cancer Genome Sequencing Market Size, 2017-2028
6.7.3 Israel Cancer Genome Sequencing Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Genome Sequencing Market Size, 2017-2028
6.7.5 UAE Cancer Genome Sequencing Market Size, 2017-2028
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Cancer Genome Sequencing Major Product Offerings
7.1.4 Agilent Technologies Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.1.5 Agilent Technologies Key News
7.2 GE Healthcare Life Sciences
7.2.1 GE Healthcare Life Sciences Corporate Summary
7.2.2 GE Healthcare Life Sciences Business Overview
7.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Major Product Offerings
7.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.2.5 GE Healthcare Life Sciences Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cancer Genome Sequencing Major Product Offerings
7.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 LI-COR Biosciences
7.4.1 LI-COR Biosciences Corporate Summary
7.4.2 LI-COR Biosciences Business Overview
7.4.3 LI-COR Biosciences Cancer Genome Sequencing Major Product Offerings
7.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.4.5 LI-COR Biosciences Key News
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Corporate Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Cancer Genome Sequencing Major Product Offerings
7.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.5.5 Abbott Laboratories Key News
7.6 Beckman Coulter
7.6.1 Beckman Coulter Corporate Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Cancer Genome Sequencing Major Product Offerings
7.6.4 Beckman Coulter Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.6.5 Beckman Coulter Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Cancer Genome Sequencing Major Product Offerings
7.7.4 Bayer Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.7.5 Bayer Key News
7.8 Hamilton Thorne Biosciences
7.8.1 Hamilton Thorne Biosciences Corporate Summary
7.8.2 Hamilton Thorne Biosciences Business Overview
7.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Major Product Offerings
7.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.8.5 Hamilton Thorne Biosciences Key News
7.9 Integrated DNA Technologies
7.9.1 Integrated DNA Technologies Corporate Summary
7.9.2 Integrated DNA Technologies Business Overview
7.9.3 Integrated DNA Technologies Cancer Genome Sequencing Major Product Offerings
7.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.9.5 Integrated DNA Technologies Key News
7.10 Microchip Biotechnologies
7.10.1 Microchip Biotechnologies Corporate Summary
7.10.2 Microchip Biotechnologies Business Overview
7.10.3 Microchip Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.10.5 Microchip Biotechnologies Key News
7.11 Myriad Genetics
7.11.1 Myriad Genetics Corporate Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Genome Sequencing Major Product Offerings
7.11.4 Myriad Genetics Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.11.5 Myriad Genetics Key News
7.12 Commonwealth Biotechnologies
7.12.1 Commonwealth Biotechnologies Corporate Summary
7.12.2 Commonwealth Biotechnologies Business Overview
7.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.12.5 Commonwealth Biotechnologies Key News
7.13 ZS Genetics
7.13.1 ZS Genetics Corporate Summary
7.13.2 ZS Genetics Business Overview
7.13.3 ZS Genetics Cancer Genome Sequencing Major Product Offerings
7.13.4 ZS Genetics Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.13.5 ZS Genetics Key News
7.14 Pacific Biosciences
7.14.1 Pacific Biosciences Corporate Summary
7.14.2 Pacific Biosciences Business Overview
7.14.3 Pacific Biosciences Cancer Genome Sequencing Major Product Offerings
7.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue in Global Market (2017-2022)
7.14.5 Pacific Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Genome Sequencing Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Sequencing Market Drivers in Global Market
Table 3. Cancer Genome Sequencing Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Sequencing in Global Market
Table 5. Top Cancer Genome Sequencing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Genome Sequencing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Genome Sequencing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Genome Sequencing Product Type
Table 9. List of Global Tier 1 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2023-2028
Table 30. Agilent Technologies Corporate Summary
Table 31. Agilent Technologies Cancer Genome Sequencing Product Offerings
Table 32. Agilent Technologies Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 33. GE Healthcare Life Sciences Corporate Summary
Table 34. GE Healthcare Life Sciences Cancer Genome Sequencing Product Offerings
Table 35. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Cancer Genome Sequencing Product Offerings
Table 38. Johnson & Johnson Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 39. LI-COR Biosciences Corporate Summary
Table 40. LI-COR Biosciences Cancer Genome Sequencing Product Offerings
Table 41. LI-COR Biosciences Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories Cancer Genome Sequencing Product Offerings
Table 44. Abbott Laboratories Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 45. Beckman Coulter Corporate Summary
Table 46. Beckman Coulter Cancer Genome Sequencing Product Offerings
Table 47. Beckman Coulter Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Cancer Genome Sequencing Product Offerings
Table 50. Bayer Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 51. Hamilton Thorne Biosciences Corporate Summary
Table 52. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offerings
Table 53. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 54. Integrated DNA Technologies Corporate Summary
Table 55. Integrated DNA Technologies Cancer Genome Sequencing Product Offerings
Table 56. Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 57. Microchip Biotechnologies Corporate Summary
Table 58. Microchip Biotechnologies Cancer Genome Sequencing Product Offerings
Table 59. Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 60. Myriad Genetics Corporate Summary
Table 61. Myriad Genetics Cancer Genome Sequencing Product Offerings
Table 62. Myriad Genetics Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 63. Commonwealth Biotechnologies Corporate Summary
Table 64. Commonwealth Biotechnologies Cancer Genome Sequencing Product Offerings
Table 65. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 66. ZS Genetics Corporate Summary
Table 67. ZS Genetics Cancer Genome Sequencing Product Offerings
Table 68. ZS Genetics Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
Table 69. Pacific Biosciences Corporate Summary
Table 70. Pacific Biosciences Cancer Genome Sequencing Product Offerings
Table 71. Pacific Biosciences Cancer Genome Sequencing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Genome Sequencing Segment by Type in 2021
Figure 2. Cancer Genome Sequencing Segment by Application in 2021
Figure 3. Global Cancer Genome Sequencing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Genome Sequencing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Genome Sequencing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2021
Figure 8. By Type - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 12. US Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 24. China Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Genome Sequencing Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Genome Sequencing Revenue, (US$, Mn), 2017-2028
Figure 37. Agilent Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LI-COR Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Laboratories Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beckman Coulter Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Integrated DNA Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Microchip Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Myriad Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ZS Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pacific Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
